Bruker Corporation

12/02/2021 | Press release | Distributed by Public on 12/02/2021 10:48

Bruker Expects its FluoroType® SARS-CoV-2 varID Q PCR Assay to Reliably Detect and Tentatively Differentiate Omicron (B.1.1.529) Variant